MetaCap

Nurix Therapeutics (NRIX) News

NASDAQ: NRIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.85-0.755 (-5.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NRIX news summary

We found 13 recent headlines mentioning Nurix Therapeutics (NRIX): 1 in the past week and 6 in the past 30 days, most often from Nasdaq, GlobeNewswire, Investing.com. NRIX is making an outsized move today, down 5.55% at $12.85, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "RHHBY Secures FDA Approval for Breast Cancer Treatment", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Nurix Therapeutics headlines

Stocks mentioned alongside NRIX

Compare NRIX